These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35027444)

  • 1. Subcortical volumetric alterations as potential predictors of methylphenidate treatment response in youth with attention-deficit/hyperactivity disorder.
    Kim JS; Lee KH; Hwang CS; Kim JW
    J Psychiatry Neurosci; 2022; 47(1):E11-E20. PubMed ID: 35027444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; van der Meer D; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Child Adolesc Psychiatry; 2015 Aug; 24(8):959-68. PubMed ID: 25395383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD.
    Chang JC; Lin HY; Lv J; Tseng WI; Gau SS
    BMC Psychiatry; 2021 Jan; 21(1):26. PubMed ID: 33430830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
    Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
    Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
    Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
    CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
    Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
    J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study.
    Ricketts EJ; Sturm A; McMakin DL; McGuire JF; Tan PZ; Smalberg FB; McCracken JT; Colwell CS; Piacentini J
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):690-698. PubMed ID: 30388029
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic imaging study with [Tc-
    Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey matter volumes in treatment naïve vs. chronically treated children with attention deficit/hyperactivity disorder: a combined approach.
    Villemonteix T; De Brito SA; Kavec M; Balériaux D; Metens T; Slama H; Baijot S; Mary A; Peigneux P; Massat I
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1118-27. PubMed ID: 25934396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study.
    Hammerness P; Biederman J; Petty C; Henin A; Moore CM
    CNS Neurosci Ther; 2012 Jan; 18(1):34-40. PubMed ID: 21143432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
    Schulz KP; Bédard AV; Fan J; Hildebrandt TB; Stein MA; Ivanov I; Halperin JM; Newcorn JH
    J Am Acad Child Adolesc Psychiatry; 2017 Jul; 56(7):602-609.e2. PubMed ID: 28647012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emotional dysregulation and callous unemotional traits as possible predictors of short-term response to methylphenidate monotherapy in drug-naïve youth with ADHD.
    Masi G; Fantozzi P; Muratori P; Bertolucci G; Tacchi A; Villafranca A; Pfanner C; Cortese S
    Compr Psychiatry; 2020 Jul; 100():152178. PubMed ID: 32386957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder.
    Hong SB; Harrison BJ; Fornito A; Sohn CH; Song IC; Kim JW
    J Psychiatry Neurosci; 2015 Jan; 40(1):46-57. PubMed ID: 25266402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension.
    Weiss MD; Cutler AJ; Kollins SH; Donnelly GAE
    J Child Adolesc Psychopharmacol; 2021 Nov; 31(9):610-622. PubMed ID: 34637343
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment effect of methylphenidate on intrinsic functional brain network in medication-naïve ADHD children: A multivariate analysis.
    Yoo JH; Kim D; Choi J; Jeong B
    Brain Imaging Behav; 2018 Apr; 12(2):518-531. PubMed ID: 28417219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder.
    Arns M; Vollebregt MA; Palmer D; Spooner C; Gordon E; Kohn M; Clarke S; Elliott GR; Buitelaar JK
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):881-891. PubMed ID: 29937325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of methylphenidate intake on brain structure in adults with ADHD in a placebo-controlled randomized trial.
    Tebartz van Elst L; Maier S; Klöppel S; Graf E; Killius C; Rump M; Sobanski E; Ebert D; Berger M; Warnke A; Matthies S; Perlov E; Philipsen A
    J Psychiatry Neurosci; 2016 Oct; 41(6):422-430. PubMed ID: 27575717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.